CSF-1R kinase inhibitor (BCI Pharma/Mithra Pharmaceuticals)

N/A

Report date: 2025/03/19 09:02:28
NME

Base Information

Drug NameCSF-1R kinase inhibitor (BCI Pharma/Mithra Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitors
TargetsMacrophage Colony Stimulating Factor 1
Therapy Area/IndicationsInflammationEndometriosisColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBCI Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMithra Pharmaceuticals SABCI Pharma
Inactive CompaniesN/A
Active IndicationsInflammationEndometriosisColorectal Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A